Platform Technology Being News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform Technology Being. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Technology Being Today - Breaking & Trending Today

Acquisition Rights Obtained for Immuno-Oncology Treatments Using CAR T Technology, Cell Therapy for Cancers NASDAQ: COEP

Published: March 29, 2023

Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Cancers: Coeptis NASDAQ: COEP

Source: einnews.com

Related Topics:

United StatesFrontpagestocks CorporateadsKarolinska InstitutetDave MehalickArnika Kathleen WagnerEvren AliciHans Gustaf LjunggrenArnika WagnerUniversity Of PittsburghPlatform Technology BeingDevelopment ProgramUniversity Of Pittsburgh ToNobel AssemblyAntigen Cart TechnologyPolaris Market ResearchCoeptis Therapeutics IncClinical DevelopmentResearch AgreementCoeptis Pharmaceuticals IncUniversity Of Pittsburgh To Expand PreVygen Bio IncCompetence CenterTechnology PlatformGlobal Contract Research OrganizationCoeptis Therapeutics Holdings Inc

NASDAQ: COEP Collaborates with the University of Pittsburgh Targeting HER2-Positive Cancers. $COEP; Illegally Short Sold

Published: February 7, 2023

$COEP is Targeting HER2-POSITIVE Cancers

Source: einnews.com

Related Topics:

United StatesKarolinska InstitutetJason LohmuellerDave MehalickAlexander DeitersFrontpagestocks CorporateadsPolaris Market ResearchDivision Of Surgical Oncology ResearchUniversity Of Pittsburgh ToGlobal Contract Research OrganizationCancer Research ProgramDevelopment ProgramUniversity Of PittsburghPlatform Technology BeingClinical DevelopmentUniversity Of Pittsburgh To Expand PreCoeptis Therapeutics IncCoeptis Pharmaceuticals IncCoeptis Therapeutics Holdings IncResearch AgreementCoeptis Therapeutics HoldingsTherapeutics HoldingsPlatform Technology Being DevelopedTumor Specific AntibodiesPotentially Target Many Different Tumor